-
1
-
-
67650874081
-
Cancer statistics, 2009
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
2
-
-
78650504704
-
Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma
-
Hu SL, Kong XY, Cheng ZD, Sun YB, Shen G, Xu WP, et al. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Tumori 2010, 96:726-733.
-
(2010)
Tumori
, vol.96
, pp. 726-733
-
-
Hu, S.L.1
Kong, X.Y.2
Cheng, Z.D.3
Sun, Y.B.4
Shen, G.5
Xu, W.P.6
-
3
-
-
84879202537
-
Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer
-
Xu L, Jiang Y, Zheng J, Xie G, Li J, Shi L, et al. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer. Hum Pathol 2013, 44:1357-1364.
-
(2013)
Hum Pathol
, vol.44
, pp. 1357-1364
-
-
Xu, L.1
Jiang, Y.2
Zheng, J.3
Xie, G.4
Li, J.5
Shi, L.6
-
4
-
-
84865346897
-
Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma
-
Luo W, Fang W, Li S, Yao K Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma. Int J Cancer 2012, 131:1863-1873.
-
(2012)
Int J Cancer
, vol.131
, pp. 1863-1873
-
-
Luo, W.1
Fang, W.2
Li, S.3
Yao, K.4
-
5
-
-
84876912182
-
Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma
-
Ma L, Zhang G, Miao XB, Deng XB, Wu Y, Liu Y, Jin ZR, et al. Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma. FEBS J 2013, 280:2027-2041.
-
(2013)
FEBS J
, vol.280
, pp. 2027-2041
-
-
Ma, L.1
Zhang, G.2
Miao, X.B.3
Deng, X.B.4
Wu, Y.5
Liu, Y.6
Jin, Z.R.7
-
6
-
-
84866555389
-
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
-
Singh S, Trevino J, Bora-Singhal N, Coppola D, Haura E, Altiok S, et al. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer. Mol Cancer 2012, 11:73.
-
(2012)
Mol Cancer
, vol.11
, pp. 73
-
-
Singh, S.1
Trevino, J.2
Bora-Singhal, N.3
Coppola, D.4
Haura, E.5
Altiok, S.6
-
7
-
-
77952242739
-
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
-
Ma BB, Lui VW, Poon FF, Wong SC, To KF, Wong E, et al. Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response. Invest New Drugs 2010, 28:326-333.
-
(2010)
Invest New Drugs
, vol.28
, pp. 326-333
-
-
Ma, B.B.1
Lui, V.W.2
Poon, F.F.3
Wong, S.C.4
To, K.F.5
Wong, E.6
-
8
-
-
84873577222
-
Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R
-
Gaujoux S, Hantel C, Launay P, Bonnet S, Perlemoine K, Lefèvre L, et al. Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R. PLoS One 2013, 8:e55743.
-
(2013)
PLoS One
, vol.8
-
-
Gaujoux, S.1
Hantel, C.2
Launay, P.3
Bonnet, S.4
Perlemoine, K.5
Lefèvre, L.6
-
9
-
-
24744454197
-
Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors
-
Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, et al. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Cancer Res 2005, 65:7622-7627.
-
(2005)
Cancer Res
, vol.65
, pp. 7622-7627
-
-
Tissier, F.1
Cavard, C.2
Groussin, L.3
Perlemoine, K.4
Fumey, G.5
Hagneré, A.M.6
-
11
-
-
48149107365
-
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
-
Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008, 372:392-397.
-
(2008)
Lancet
, vol.372
, pp. 392-397
-
-
Fukase, K.1
Kato, M.2
Kikuchi, S.3
Inoue, K.4
Uemura, N.5
Okamoto, S.6
-
12
-
-
38049130282
-
Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas
-
Tadjine M, Lampron A, Ouadi L, Bourdeau I Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clin Endocrinol (Oxf) 2008, 68:264-270.
-
(2008)
Clin Endocrinol (Oxf)
, vol.68
, pp. 264-270
-
-
Tadjine, M.1
Lampron, A.2
Ouadi, L.3
Bourdeau, I.4
-
13
-
-
84871672823
-
Role of centromere protein H and Ki67 in relapse-free survival of patients after primary surgery for hypopharyngeal cancer
-
Wang JX, Zhang YY, Yu XM, Jin T, Pan XL Role of centromere protein H and Ki67 in relapse-free survival of patients after primary surgery for hypopharyngeal cancer. Asian Pac J Cancer Prev 2012, 13:821-825.
-
(2012)
Asian Pac J Cancer Prev
, vol.13
, pp. 821-825
-
-
Wang, J.X.1
Zhang, Y.Y.2
Yu, X.M.3
Jin, T.4
Pan, X.L.5
-
14
-
-
84872149859
-
Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma
-
He WL, Li YH, Yang DJ, Song W, Chen XL, Liu FK, et al. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. Eur J Surg Oncol 2013, 39:141-149.
-
(2013)
Eur J Surg Oncol
, vol.39
, pp. 141-149
-
-
He, W.L.1
Li, Y.H.2
Yang, D.J.3
Song, W.4
Chen, X.L.5
Liu, F.K.6
-
15
-
-
84866531775
-
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer
-
Delpech Y, Wu Y, Hess KR, Hsu L, Ayers M, Natowicz R, et al. Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer. Breast Cancer Res Treat 2012, 135:619-627.
-
(2012)
Breast Cancer Res Treat
, vol.135
, pp. 619-627
-
-
Delpech, Y.1
Wu, Y.2
Hess, K.R.3
Hsu, L.4
Ayers, M.5
Natowicz, R.6
-
16
-
-
84872149859
-
Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma
-
He WL, Li YH, Yang DJ, Song W, Chen XL, Liu FK, et al. Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. Eur J Surg Oncol 2013, 39:141-149.
-
(2013)
Eur J Surg Oncol
, vol.39
, pp. 141-149
-
-
He, W.L.1
Li, Y.H.2
Yang, D.J.3
Song, W.4
Chen, X.L.5
Liu, F.K.6
-
17
-
-
84866759547
-
Metastatic gastric cancer - focus on targeted therapies
-
Meza-Junco J, Sawyer MB Metastatic gastric cancer - focus on targeted therapies. Biologics 2012, 6:137-146.
-
(2012)
Biologics
, vol.6
, pp. 137-146
-
-
Meza-Junco, J.1
Sawyer, M.B.2
|